Ikarian Capital »

Achilles Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 1.4M 0.82
2024-03-31 $1.8M 1.4M 1.25

More positions owned by Ikarian Capital

Sarepta Therapeutics Call Option (SRPT)
Amgen Call Option (AMGN)
Bridgebio Pharma Call Option (BBIO)
Immunovant Call Option (IMVT)
Neurocrine Biosciences Call Option (NBIX)
Pyxis Oncology Common Stock Call Option (PYXS)
Insmed Com Par $.01 Call Option (INSM)
Abeona Therapeutics Com New Call Option (ABEO)
Alnylam Pharmaceuticals Put Option (ALNY)
Aerovate Therapeutics Call Option (AVTE)
Rapt Therapeutics Call Option (RAPT)
Praxis Precision Medicines I Com New Call Option (PRAX)
Crinetics Pharmaceuticals In (CRNX)
Tarsus Pharmaceuticals (TARS)
Soleno Therapeutics (SLNO)

View all positions for Ikarian Capital

Top funds holding Achilles Therapeutics

Syncona Portfolio
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Baker Bros. Advisors
Artal Group
Renaissance Technologies
BML Capital Management
Acadian Asset Management
Citadel Advisors
XTX Topco
Two Sigma Advisers
Virtu Financial
Geode Capital Management

View all funds holding Achilles Therapeutics